Workflow
Aktis Oncology(AKTS)
icon
Search documents
Akoustis Secures a wBMS Design Win with Tier-1 Automotive Product Supplier
Newsfilter· 2024-01-29 12:00
First BAW Design Win at a Tier-1 Automotive Customer in the Fast-Growing EV Market Segment Based on IC Reference Design by a Leading Semiconductor Supplier Production Expected to Ramp in the March Quarter of Calendar Year 2025 Charlotte, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ:AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today t ...
Akoustis Announces Pricing of Public Offering of $10.0 Million of Common Stock
Newsfilter· 2024-01-25 14:07
Board Co-Chair, CEO, CPO, and Other Company Management and Employees Investing $1 Million Charlotte, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has priced its underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $0.50 per shar ...
Why Is Akoustis Technologies (AKTS) Stock Down 33% Today?
InvestorPlace· 2024-01-25 13:21
Group 1 - Akoustis Technologies announced a proposed public share offering, which has led to a decline in its stock price [1] - The company intends to sell shares through an underwritten public offering but has not disclosed the pricing or the number of shares [1] - Roth Capital Partners is the sole manager for the stock offering and the company plans to grant the underwriter a 30-day option to acquire additional shares [1] Group 2 - The public offering will increase the total number of outstanding shares, diluting the stakes of current investors, contributing to the stock's decline [2] - Public offerings are typically priced below the current stock value, which is likely to be the case for AKTS, further impacting the stock price negatively [2] - As of Thursday morning, AKTS stock is down 33.3% with approximately 163,000 shares traded, compared to a daily average trading volume of about 678,000 shares [2]
Akoustis Announces Proposed Public Offering of Common Stock
Newsfilter· 2024-01-24 21:47
Charlotte, N.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering.  Akoustis expects to grant the underwriters a 30-day option to purchase additional shares of common stock sold in the offering solel ...
Akoustis Receives Wi-Fi 7 Design Win from Tier-1 Enterprise Wi-Fi AP Provider
Newsfilter· 2024-01-10 12:00
Second Tier-1 Customer to Use Multiple Akoustis 5 GHz and 6 GHz Wi-Fi 7 Filters for a 4X4 MU-MIMO AP PlatformHas Received Prototype Orders to Enable Production Ramp in the Second Half Calendar Year 2024 Charlotte, N.C., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ:AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that five of its patented ...
Aktis Oncology(AKTS) - 2024 Q1 - Earnings Call Transcript
2023-11-13 15:26
Akoustis Technologies, Inc. (NASDAQ:AKTS) Q1 2024 Earnings Conference Call November 13, 2023 8:00 AM ET Company Participants Tom Sepenzis - IR Jeff Shealy - Founder & CEO Ken Boller - CFO Dave Aichele - EVP of Business Development Conference Call Participants Anthony Stoss - Craig-Hallum Craig Ellis - B. Riley Securities Suji Desilva - ROTH MKM Operator Good day, ladies and gentlemen, and welcome to the Akoustis Technologies Fiscal 2024 First Quarter Conference Call. As a reminder, this conference call is b ...
Akoustis Technologies(AKTS) - 2024 Q1 - Quarterly Report
2023-11-12 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-38029 AKOUSTIS TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) | Delaware | ...
Aktis Oncology(AKTS) - 2023 Q4 - Earnings Call Transcript
2023-09-06 15:23
Financial Data and Key Metrics Changes - For Q4 2023, the company reported revenue of $8.3 million, a 13% increase from the previous quarter and a 60% year-over-year increase [21] - The GAAP operating loss was $17.9 million, with a GAAP net loss per share of $0.25 [22] - Cash used in operating activities was $8.7 million, showing a 12% improvement from the prior quarter [22] - The company exited Q4 with $43.1 million in cash and cash equivalents, down from $52.7 million in the previous quarter [22] Business Line Data and Key Metrics Changes - Filter product revenue grew by 41% sequentially, driven by Wi-Fi 6E demand and shipments to a tier-1 5G mobile RF component customer [5] - The top 10 customers accounted for 63% of revenue, with the top two customers increasing their sequential revenue by 18% and 3% respectively [6] Market Data and Key Metrics Changes - The company is experiencing challenges in the consumer electronics market due to high component inventory levels and weak demand, particularly in mobile handsets [7] - Revenue for the September quarter is expected to decline by approximately 15% due to broader market weakness [23] Company Strategy and Development Direction - The company is focusing on expanding its domestic manufacturing footprint under the CHIPS Act, with plans to file a final application by the end of the calendar year [9] - New product introductions and design wins are expected to drive substantial revenue growth over the next 24 months [7][26] Management's Comments on Operating Environment and Future Outlook - Management noted a challenging macro environment but remains optimistic about new design wins and product introductions [7][25] - The company expects to see a rebound in revenue as inventory levels normalize in 2024 [12] Other Important Information - The company is actively involved in litigation with Qorvo, with ongoing developments in both lawsuits [24][25] - The introduction of new XP3F technology is expected to create significant opportunities in defense and commercial markets [20] Q&A Session Summary Question: Wi-Fi 7 volume revenue expectations - Management expects Wi-Fi 7 activity to pick up in Q2 of next year, with engagements in both carrier and enterprise sectors [31] Question: Smartphone tablet customer audit - The successful audit is a significant milestone, and management will provide better guidance as traction with the customer develops [32] Question: Gross margins and cash flow breakeven - Management is implementing initiatives to improve gross margins and expects to reach cash flow breakeven in Q4 2024 with revenue of $15 million to $18 million per quarter [36][37] Question: September quarter revenue decline - Management anticipates a 15% decline in revenue for the September quarter, with some softness expected to continue into the December quarter [40][42] Question: Mobile market production ramp - Management indicated that visibility into the China mobile market is limited, and they will provide updates as trends improve [46] Question: Updates on CHIPS Act funding - Management will provide updates on potential funding in early November, as contract negotiations are ongoing [50]
Akoustis Technologies(AKTS) - 2023 Q4 - Annual Report
2023-09-05 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________________ to ____________________ Commission file number: 001-38029 AKOUSTIS TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) | Delaware | 33-1229046 | | --- | --- | | (St ...
Aktis Oncology(AKTS) - 2023 Q3 - Earnings Call Transcript
2023-05-08 17:57
Akoustis Technologies, Inc. (NASDAQ:AKTS) Q3 2023 Earnings Conference Call May 8, 2023 8:00 AM ET Company Participants Tom Sepenzis - VP of Corporate Development & IR Jeff Shealy - Founder & CEO Ken Boller - CFO David Aichele - EVP of Business Development Conference Call Participants Anthony Stoss - Craig-Hallum Capital Group Suji Desilva - ROTH Robert Argano - Piper Sandler Operator Good day, ladies and gentlemen, and welcome to the cTechnologies Fiscal 2020 Third Quarter Conference Call. As a reminder, th ...